Allergan Sues Watson, Paddock Over Generic Sanctura
Allergan Inc. and others have accused Paddock Laboratories Inc. and Watson Pharmaceuticals Inc. of infringing two patents through plans to market generic versions of overactive bladder drug Sanctura XR....To view the full article, register now.
Already a subscriber? Click here to view full article